Search Results - "Ocak, Meltem"

Refine Results
  1. 1

    Application of response surface methodology and quality by design to [68Ga]Ga-PSMA-11 preparation by Pehlivanoglu, Huseyin, Ocak, Meltem, Caglar-Andac, Sena

    “…In this study, the optimum conditions for the synthesis of [ 68 Ga]Ga-PSMA-11 were determined for the first time using the Quality by Design (QbD). The…”
    Get full text
    Journal Article
  2. 2

    EANM guideline on the validation of analytical methods for radiopharmaceuticals by Gillings, Nic, Todde, Sergio, Behe, Martin, Decristoforo, Clemens, Elsinga, Philip, Ferrari, Valentina, Hjelstuen, Olaug, Peitl, Petra Kolenc, Koziorowski, Jacek, Laverman, Peter, Mindt, Thomas L., Ocak, Meltem, Patt, Marianne

    Published in EJNMMI radiopharmacy and chemistry (12-02-2020)
    “…Background To fulfil good manufacturing requirements, analytical methods for the analysis of pharmaceuticals for human and vetinary use must be validated. The…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT by Asa, Sertac, Sonmezoglu, Kerim, Uslu-Besli, Lebriz, Sahin, Onur Erdem, Karayel, Emre, Pehlivanoglu, Huseyin, Sager, Sait, Kabasakal, Levent, Ocak, Meltem, Sayman, Haluk B.

    Published in Annals of nuclear medicine (01-08-2021)
    “…Objective PET imaging with F-18 DOPA (FDOPA) and Ga-68 DOTATATE (TATE) shows the most promising results to detect medullary thyroid cancer (MTC) recurrence. We…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Folate Receptor-Targeted Multimodality Imaging of Ovarian Cancer in a Novel Syngeneic Mouse Model by Ocak, Meltem, Gillman, Andrea G, Bresee, Jamee, Zhang, Lixin, Vlad, Anda M, Müller, Cristina, Schibli, Roger, Edwards, W. Barry, Anderson, Carolyn J, Gach, H. Michael

    Published in Molecular pharmaceutics (02-02-2015)
    “…A new transplantable ovarian tumor model is presented using a novel folate receptor (FR) positive, murine ovarian cancer cell line that emulates the human…”
    Get full text
    Journal Article
  8. 8

    Preclinical Evaluation of F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors by Emre Demirci MD, Rafay Ahmed MD, Meltem Ocak PhD, Joseph Latoche BS, April Radelet BS, Nicole DeBlasio BS, N. Scott Mason PhD, Carolyn J. Anderson PhD, James M. Mountz MD, PhD

    Published in Molecular imaging (01-01-2017)
    “…Purpose: We investigated 2-(5-fluoro-pentyl)-2-methyl-malonic acid ( 18 F-ML-10) positron emission tomography (PET) imaging of apoptosis posttherapy to…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Radiolabelling of peptides for PET, SPECT and therapeutic applications using a fully automated disposable cassette system by Petrik, Milos, Knetsch, Peter A, Knopp, Roger, Imperato, Giovanni, Ocak, Meltem, von Guggenberg, Elisabeth, Haubner, Roland, Silbernagl, Roland, Decristoforo, Clemens

    Published in Nuclear medicine communications (01-10-2011)
    “…OBJECTIVESRadiolabelled somatostatin analogues have found wide clinical use in nuclear medicine for both diagnostic and therapeutic applications. Here, we…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours by Kabasakal, Levent, Demirci, Emre, Ocak, Meltem, Decristoforo, Clemens, Araman, Ahmet, Ozsoy, Yıldız, Uslu, Ilhami, Kanmaz, Bedii

    “…Purpose Recent studies have suggested that positron emission tomography (PET) imaging with 68 Ga-labelled DOTA-somatostatin analogues (SST) like octreotide and…”
    Get full text
    Journal Article
  15. 15

    Clinical Experience with [ 225 Ac]Ac-PSMA Treatment in Patients with [ 177 Lu]Lu-PSMA–Refractory Metastatic Castration-Resistant Prostate Cancer by Alan-Selcuk, Nalan, Beydagi, Gamze, Demirci, Emre, Ocak, Meltem, Celik, Serkan, Oven, Bala B., Toklu, Turkay, Karaaslan, Ipek, Akcay, Kaan, Sonmez, Omer, Kabasakal, Levent

    Published in Journal of Nuclear Medicine (01-10-2023)
    “…For patients with advanced-stage metastatic castration-resistant prostate cancer (mCRPC) who do not respond to [177Lu]Lu-PSMA therapy, there are limited…”
    Get full text
    Journal Article
  16. 16

    Development and validation of a UV-Radio-HPLC method to assess chemical and radiochemical purity of [68Ga] Ga-PSMA-11 by Pehli̇vanoglu, Huseyin, Ocak, Meltem, Caglar-Andac, Sena

    Published in Applied radiation and isotopes (01-12-2022)
    “…[68Ga]Ga-PSMA-11, a urea-based peptidomimetic, has been widely used in recent years for PET imaging of patients with prostate cancer. Since it has short…”
    Get full text
    Journal Article
  17. 17

    Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria by Demirci, Emre, Akyel, Reşit, Caner, Biray, Alan-Selçuk, Nalan, Güven-Meşe, Şermin, Ocak, Meltem, Kabasakal, Levent

    Published in Nuclear medicine communications (01-08-2020)
    “…AIMIn this study, we aimed to measure interobserver and intraobserver agreement in Ga-68–prostate-specific membrane antigen (PSMA) PET/computed tomography (CT)…”
    Get full text
    Journal Article
  18. 18

    EANM guideline on quality risk management for radiopharmaceuticals by Gillings, Nic, Hjelstuen, Olaug, Behe, Martin, Decristoforo, Clemens, Elsinga, Philip H., Ferrari, Valentina, Kiss, Oliver C., Kolenc, Petra, Koziorowski, Jacek, Laverman, Peter, Mindt, Thomas L., Ocak, Meltem, Patt, Marianne, Todde, Sergio, Walte, Almut

    “…This document is intended as a supplement to the EANM “Guidelines on current Good Radiopharmacy Practice (cGRPP)” issued by the Radiopharmacy Committee of the…”
    Get full text
    Journal Article
  19. 19

    The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels by Kabasakal, Levent, Demirci, Emre, Nematyazar, Jamal, Akyel, Reşit, Razavi, Baresh, Ocak, Meltem, Aygun, Aslan, Obek, Can, Kural, Ali R

    Published in Nuclear medicine communications (01-02-2017)
    “…INTRODUCTIONProstate-specific membrane antigen (PSMA) is increasingly being recognized as a novel target for the PET imaging of prostate cancer (PCa) and…”
    Get full text
    Journal Article
  20. 20